All Stories

  1. Tumour contact surface area as a predictor of postoperative complications and renal function in patients undergoing partial nephrectomy for renal tumours
  2. Cognitive training for technical and non-technical skills in robotic surgery: a randomised controlled trial
  3. Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node-positive prostate cancer patients: External validation on a multi-institutional database
  4. Robot-assisted vs open radical prostatectomy: the day after
  5. Anatomical study of renal arterial vasculature and its potential impact on partial nephrectomy
  6. Risk stratification for benign prostatic hyperplasia
  7. Minimally invasive surgery or nephron preservation for small renal tumours?
  8. Robot-assisted partial nephrectomy in cystic tumours: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database
  9. Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data
  10. Histopathological characteristics of microfocal prostate cancer detected during systematic prostate biopsy
  11. Gonadotropin-releasing Hormone Agonists and Acute Kidney Injury in Patients with Prostate Cancer
  12. Is surgery a never-ending learning process?
  13. Postoperative nomogram to predict cancer‐specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis
  14. Critical analysis of phase II and III randomised control trials (RCTs) evaluating efficacy and tolerability of a β3-adrenoceptor agonist (Mirabegron) for overactive bladder (OAB)
  15. On the Way Toward Better Evidence for Minimally Invasive Treatment of Pelvic Organ Prolapse
  16. Corrigendum to “Why and How to Evaluate Chronic Prostatic Inflammation” [Eur Urol Suppl 2013;12:110–5]
  17. Impact of Medical Treatments for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia on Ejaculatory Function: A Systematic Review and Meta‐Analysis
  18. The Role of Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection in the Management of High-risk Prostate Cancer: A Systematic Review
  19. An Updated Systematic Review and Statistical Comparison of Standardised Mean Outcomes for the Use of Botulinum Toxin in the Management of Lower Urinary Tract Disorders
  20. Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder
  21. Complications and outcomes of salvage robot‐assisted radical prostatectomy: a single‐institution experience
  22. MP59-19 ASSESSMENT OF PREDICTORS OF RENAL FUNCTION IMPAIRMENT AFTER ROBOT-ASSISTED PARTIAL NEPHRECTOMY
  23. MP55-11 DEVELOPMENT AND EXTERNAL VALIDATION OF NOMOGRAMS PREDICTING DISEASE-FREE AND CANCER SPECIFIC SURVIVAL AFTER RADICAL CYSTETCOMY
  24. PD35-06 POST-OPERATIVE NOMOGRAM TO PREDICT CANCER-SPECIFIC SURVIVAL AFTER RADICAL NEPHROURETERECTOMY IN PATIENTS WITH PT1-T3 N0/NX UPPER TRACT UROTHELIAL CARCINOMA WITHOUT METASTASIS
  25. Female Gender Is Associated With a Worse Survival After Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Competing Risk Analysis
  26. A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non‐neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)
  27. Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool
  28. Predicting the risk of bone metastasis in prostate cancer
  29. Advanced kidney cancer: treating the elderly
  30. Why and How to Evaluate Chronic Prostatic Inflammation
  31. Extranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients with Lymph Node Metastasis
  32. Characterizing late recurrence of renal cell carcinoma
  33. Impact of Smoking and Smoking Cessation on Outcomes in Bladder Cancer Patients Treated with Radical Cystectomy
  34. Medical Treatment of LUTS/BPH
  35. Surgical Treatment of Recurrent Stress Urinary Incontinence in Women: A Systematic Review and Meta-analysis of Randomised Controlled Trials
  36. Systematic Review of Combination Drug Therapy for Non-neurogenic Male Lower Urinary Tract Symptoms
  37. Robot‐assisted vs traditional laparoscopic partial nephrectomy: the time for meta‐analysis has not yet arrived
  38. Erratum to: Systematic review and meta-analysis of randomized controlled trials evaluating silodosin in the treatment of non-neurogenic male lower urinary tract symptoms suggestive of benign prostatic enlargement
  39. Effect of statin use on outcomes of non‐muscle‐invasive bladder cancer
  40. Expanding utilization of robotic partial nephrectomy for clinical T1b and complex T1a renal masses
  41. Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: adjusting for the burden of ensuing chronic kidney disease
  42. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)
  43. Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non–muscle-invasive Bladder Cancer
  44. 1074 IMPACT OF CLINICAL AND HISTOPATHOLOGICAL PARAMETERS ON DISEASE-SPECIFIC SURVIVAL IN PATIENTS WITH COLLECTING DUCT RENAL CELL CARCINOMA
  45. The European Association of Urology Robotic Urology Section (ERUS) survey of robot‐assisted radical prostatectomy (RARP)
  46. 1445 DOES CIGARETTE SMOKING AND SMOKING CESSATION INFLUENCE OUTCOMES IN BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY?
  47. 896 PREDICTION OF INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY: DEVELOPMENT OF A CLINICAL DECISION-MAKING TOOL
  48. 741 TIME TO RECURRENCE IS A SIGNIFICANT PREDICTOR OF CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RECURRENT RENAL CELL CARCINOMA - RESULTS FROM A COMPREHENSIVE MULTI-CENTER DATABASE (CORONA/SATURN-PROJECT)
  49. 742 FEATURES ASSOCIATED WITH RECURRENCE BEYOND 5 YEARS AFTER NEPHRECTOMY AND NEPHRON-SPARING SURGERY FOR RENAL CELL CARCINOMA: DEVELOPMENT AND INTERNAL VALIDATION OF A RISK-MODEL TO PREDICT LATE RECURRENCE BASED ON A LARGE MULTI-CENTER DATABASE (CORONA...
  50. Long‐term evaluation of survival, continence and potency (SCP) outcomes after robot‐assisted radical prostatectomy (RARP)
  51. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro‐ureterectomy
  52. Reply to Michael Froehner and Manfred P. Wirth's Letter to the Editor re: Vincenzo Ficarra, Giacomo Novara, Raymond C. Rosen, et al. Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prost...
  53. Reply to Robert P. Myers’ Letter to the Editor re: Francesco Montorsi, Timothy G. Wilson, Raymond C. Rosen, et al. Best Practices in Robot-assisted Radical Prostatectomy: Recommendations of the Pasadena Consensus Panel. Eur Urol 2012;62:368–81
  54. Reply to Stefano C.M. Picozzi, Cristian Ricci and Luca Carmignani's Letter to the Editor re: Giacomo Novara, Vincenzo Ficarra, Simone Mocellin, et al. Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radic...
  55. Mirabegron as a New Class of Oral Drug for Overactive Bladder Syndrome: Many Positive Perspectives, Some Concerns
  56. Re: Giacomo Novara, Vincenzo Ficarra, Simone Mocellin, et al. Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radical Prostatectomy. Eur Urol 2012;62:382–404
  57. Prediction of True Nodal Status in Patients with Pathological Lymph Node Negative Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy
  58. Pathologic Nodal Staging Score for Bladder Cancer: A Decision Tool for Adjuvant Therapy After Radical Cystectomy
  59. Standardized comparison of robot‐assisted limited and extended pelvic lymphadenectomy for prostate cancer
  60. Smoking Reduces the Efficacy of Intravesical Bacillus Calmette-Guérin Immunotherapy in Non–muscle-invasive Bladder Cancer
  61. Epidemiologic studies and changing clinical practice
  62. Re: Adverse Effects of Robotic-assisted Laparoscopic Versus Open Retropubic Radical Prostatectomy Among a Nationwide Random Sample of Medicare-age Men
  63. Varicocele repair for infertility
  64. Predictors of Survival in Patients With Soft Tissue Surgical Margin Involvement at Radical Cystectomy
  65. Re: A Randomized Trial of Urodynamic Testing Before Stress-incontinence Surgery
  66. Stage-Specific Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical Surgery
  67. Systematic review and meta-analysis of randomized controlled trials evaluating silodosin in the treatment of non-neurogenic male lower urinary tract symptoms suggestive of benign prostatic enlargement
  68. Robot-assisted partial nephrectomy for renal tumors larger than 4 cm: results of a multicenter, international series
  69. Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy
  70. Systematic Review and Meta-analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Prostatectomy
  71. Best Practices in Robot-assisted Radical Prostatectomy: Recommendations of the Pasadena Consensus Panel
  72. Systematic Review and Meta-analysis of Studies Reporting Potency Rates After Robot-assisted Radical Prostatectomy
  73. Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radical Prostatectomy
  74. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma
  75. External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma
  76. AdVance Sling in Postprostatectomy Urinary Incontinence: More Data Available and Some Questions Still Open
  77. Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature
  78. The answer of the Bacteriology Laboratory to new clinical needs. Rapid sepsis diagnotics at the Novara hospital
  79. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy
  80. Multifocal Carcinoma In Situ of the Upper Tract Is Associated With High Risk of Bladder Cancer Recurrence
  81. Prognostic role of tumour multifocality in renal cell carcinoma
  82. 1906 POSITIVE SURGICAL MARGINS CONTRIBUTE TO DELAYED FAILURES IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER
  83. 638 INTERNATIONAL VALIDATION OF THE PROGNOSTIC VALUE OF SUBCLASSIFICATION FOR AJCC STAGE PT3 UPPER TRACT UROTHELIAL CARCINOMA OF THE RENAL PELVIS
  84. 392 DISEASE-FREE SURVIVAL AS A SURROGATE FOR 5-YEAR OVERALL SURVIVAL IN UPPER TRACT UROTHELIAL CARCINOMA
  85. 1904 EXTRANODAL EXTENSION IS A POWERFUL PROGNOSTIC FACTOR IN BLADDER CANCER PATIENTS WITH LYMPH NODE METASTASIS
  86. Systematic Review of Methods for Reporting Combined Outcomes After Radical Prostatectomy and Proposal of a Novel System: The Survival, Continence, and Potency (SCP) Classification
  87. Editorial Comment
  88. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy
  89. Clinical impact of body mass index on the outcome of the SPARC-sling system for the treatment of female stress urinary incontinence
  90. Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: Research Priorities
  91. Zero-ischemia partial nephrectomy—further evaluations are needed
  92. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series
  93. Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy
  94. Slings in surgery of genuine stress incontinence
  95. Is Laparoscopic Cryoablation a Less Invasive and Effective Procedure to Treat Small Renal Masses?
  96. Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi‐institutional study
  97. Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study
  98. Prognostic factors in a large multi‐institutional series of papillary renal cell carcinoma
  99. Prognostic factors for upper urinary tract urothelial carcinoma
  100. Obesity Adversely Impacts Disease Specific Outcomes in Patients With Upper Tract Urothelial Carcinoma
  101. Predictive factors of recurrence and survival of upper tract urothelial carcinomas
  102. Contemporary Management of Postprostatectomy Incontinence
  103. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study
  104. Robotic radical prostatectomy: a critical analysis of the impact on cancer control
  105. Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy
  106. Reply
  107. Trans-rectal Versus Trans-Perineal Saturation Rebiopsy of the Prostate: Is There a Difference in Cancer Detection Rate?
  108. 1892 PT2 SUBSTAGING IN UROTHELIAL CARCINOMA OF THE BLADDER: DEEP MUSCLE INVASION IS ASSOCIATED WITH WORSE OUTCOME
  109. 1898 CLINICAL CARCINOMA IN SITU ONLY DISEASE: OUTCOMES OF PATIENTS TREATED WITH RADICAL CYSTECTOMY
  110. 650 COMPARATIVE OUTCOME ANALYSIS OF OPEN VERSUS ROBOTIC-ASSISTED RADICAL PROSTATECTOMY MATCHED BY D'AMICO RISK CATEGORY
  111. 1992 HEAD-TO-HEAD COMPARISON OF THE MOST RELEVANT INTEGRATED PROGNOSTIC SYSTEMS PREDICTING CANCER-SPECIFIC SURVIVAL IN CLEAR CELL RENAL CELL CARCINOMA
  112. 651 COMPARATIVE ONCOLOGIC EFFECTIVENESS OF OPEN VERSUS ROBOTIC-ASSISTED RADICAL PROSTATECTOMY IN PATIENTS WITH EXTRACAPSULAR EXTENSION AND/OR SEMINAL VESICLE INVASION
  113. 1207 BIOCHEMICAL FAILURE IN D'AMICO LOW RISK PATIENTS WITH GLEASON SUM UPGRADING FOLLOWING RADICAL PROSTATECTOMY: AN INTERNATIONAL, MULTI-INSTITUTIONAL STUDY
  114. 1418 PROGNOSTIC TOOL TO HELP IDENTIFY PT1-3N0 PATIENTS LIKELY TO BENEFIT FROM ADJUVANT CHEMOTHERAPY AFTER RADICAL CYSTECTOMY
  115. 350 OUTCOMES OF OPEN VERSUS ROBOTIC-ASSISTED RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A MULTI-INSTITUTION STUDY ON 13,567 MEN
  116. 1982 NODAL YIELD IS NOT INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITHOUT NODAL METASTASIS AT RADICAL CYSTECTOMY
  117. Population-based analyses of radical cystectomy and urinary diversion for bladder cancer in northern Italy
  118. Is Robot-Assisted Radical Cystectomy the Right Way to Reduce Complications in Patients Undergoing Radical Cystectomy?
  119. Validation of the preoperative aspects and dimensions used for an anatomical (PADUA) score in a robot-assisted partial nephrectomy series
  120. Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours
  121. Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients
  122. Prognostic Indicators in Penile Cancer
  123. Painless Scrotal Lumps: Classification and Clinics
  124. Surgical Mesh Reconstruction for Post-hysterectomy Vaginal Vault Prolapse
  125. Corrigendum to “Validation of the 2009 TNM Version in a Large Multi-Institutional Cohort of Patients Treated for Renal Cell Carcinoma: Are Further Improvements Needed?” [Eur Urol 2010;58:588–95]
  126. Trifecta outcomes after robot‐assisted laparoscopic radical prostatectomy
  127. Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy
  128. Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort
  129. Prognostic and Therapeutic Impact of the Histopathologic Definition of Parenchymal Epithelial Renal Tumors
  130. Association of Tumor Necrosis With Pathological Features and Clinical Outcome in 754 Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An International Validation Study
  131. Reply from Authors re: Scott Eggener. TNM Staging for Renal Cell Carcinoma: Time for a New Method. Eur Urol 2010;58:517–9
  132. Reply from Authors re: Vincenzo Ficarra, Giacomo Novara, Filiberto Zattoni, The role of the prostate cancer antigen 3 (PCA3) test for the diagnosis of prostate cancer in the era of opportunistic prostate-specific antigen screening, Eur Urol 2010;58:482–4
  133. The Role of the Prostate Cancer Antigen 3 (PCA3) Test for the Diagnosis of Prostate Cancer in the Era of Opportunistic Prostate-Specific Antigen Screening
  134. Influence of Gender on Outcome following Radical Cystectomy: A Competing Risk Analysis
  135. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma
  136. Stage pT0 at Radical Cystectomy Confers Improved Survival: An International Study of 4,430 Patients
  137. Does Routine Second Transurethral Resection Affect the Long-Term Outcome of Patients with T1 Bladder Cancer? Why a Flawed Randomized Controlled Trial Cannot Address the Issue
  138. Updated Systematic Review and Meta-Analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence
  139. Author reply: Neoadjuvant targeted therapy in renal cell carcinoma
  140. Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome
  141. Functional Results Following Vescica Ileale Padovana (VIP) Neobladder: Midterm Follow-up Analysis with Validated Questionnaires
  142. Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma of the Upper Urinary Tract: An International Validation Study
  143. Downsides of Robot-assisted Laparoscopic Radical Prostatectomy: Limitations and Complications
  144. Trends from 1999 to 2007 in the surgical treatments of kidney cancer in Europe: data from the Veneto Region, Italy
  145. Detection rate and factors predictive the presence of prostate cancer in patients undergoing ultrasonography‐guided transperineal saturation biopsies of the prostate
  146. 1751 12-MONTH URINARY CONTINENCE FOLLOWING ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY
  147. 313 ADJUVANT CHEMOTHERAPY FOR UROTHELIAL CARCINOMA OF THE URINARY BLADDER
  148. 418 PROGNOSTIC SIGNIFICANCE OF TUMOR LOCATION IN UPPER TRACT UROTHELIAL CARCINOMA
  149. 1825 CLINICAL OUTCOME IN PATIENTS WITH PT4 UROTHELIAL CARCINOMA AT RADICAL CYSTECTOMY
  150. 415 PROGNOSTIC VALUE OF CONCOMITANT CARCINOMA IN SITU IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA
  151. 157 LYMPHOVASCULAR INVASION IS A PATHOLOGIC FEATURE OF BIOLOGICALLY AGGRESSIVE DISEASE IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT: AN INTERNATIONAL EXTERNAL VALIDATION STUDY
  152. 1032 VALIDATION OF RESIDUAL PATHOLOGIC STAGE AT RADICAL CYSTECTOMY AS A PROGNOSTIC FACTOR IN PATIENTS WITH CT2N0 BLADDER CANCER
  153. Prospective Evaluation With Standardised Criteria for Postoperative Complications After Robotic-Assisted Laparoscopic Radical Prostatectomy
  154. Neoadjuvant targeted therapies in renal cell carcinoma
  155. Preoperative Criteria to Select Patients for Bilateral Nerve-sparing Robotic-assisted Radical Prostatectomy
  156. Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy
  157. Factors Predicting Health-Related Quality of Life Recovery in Patients Undergoing Surgical Treatment for Renal Tumors: Prospective Evaluation Using the RAND SF-36 Health Survey
  158. Evidence-based Medicine: The Supporting Pillar of Trial Registration
  159. Predictors of Positive Surgical Margins After Laparoscopic Robot Assisted Radical Prostatectomy
  160. The Use of Simplified Versions of the Fuhrman Nuclear Grading System in Clinical Practice Requires the Agreement of a Multidisciplinary Panel of Experts
  161. Editorial Comment on: Systematic Review and Meta-Analysis of Robotic-Assisted versus Conventional Laparoscopic Pyeloplasty for Patients with Ureteropelvic Junction Obstruction: Effect on Operative Time, Length of Hospital Stay, Postoperative Complicati...
  162. Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) Classification of Renal Tumours in Patients who are Candidates for Nephron-Sparing Surgery
  163. Editorial Comment on: Urinary Nerve Growth Factor Levels are Elevated in Patients with Detrusor Overactivity and Decreased in Responders to Detrusor Botulinum Toxin-A Injection
  164. Complications and Mortality After Radical Cystectomy for Bladder Transitional Cell Cancer
  165. Editorial Comment on: Basic Mechanisms of Urgency: Preclinical and Clinical Evidence
  166. A prospective, non‐randomized trial comparing robot‐assisted laparoscopic and retropubic radical prostatectomy in one European institution
  167. Editorial Comment on: Mode-of-Action, Efficacy, and Safety of a Homologous Multi-Epitope Vaccine in a Murine Model for Adjuvant Treatment of Renal Cell Carcinoma
  168. Reply to David R. Staskin and Michael G. Oefelein's Letter to the Editor re: Giacomo Novara, Antonio Galfano, Silvia Secco, et al. A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive bladder. E...
  169. Editorial Comment on: Impact of C-Reactive Protein Kinetics on Survival of Patients with Metastatic Renal Cell Carcinoma
  170. Retropubic, Laparoscopic, and Robot-Assisted Radical Prostatectomy: A Systematic Review and Cumulative Analysis of Comparative Studies
  171. Re: Francesco Montorsi, Gerald Brock, Jay Lee, et al. Effect of Nightly versus On-Demand Vardenafil on Recovery of Erectile Function in Men Following Bilateral Nerve-Sparing Radical Prostatectomy. Eur Urol 2008;54:924–31
  172. Editorial Comment on: Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature Review
  173. COMPARISON BETWEEN TRANSRECTAL AND TRANSPERINEAL PROSTATE CANCER DETECTION RATE AT SATURATION BIOPSY AFTER PREVIOUS NEGATIVE BIOPSIES. RESULTS OF A TWO-INSTITUTION EXPERIENCE
  174. PROGNOSTIC ROLE OF CHROMOSOME 9P DELETION IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA
  175. Improvement of seminal parameters and pregnancy rates after antegrade sclerotherapy of internal spermatic veins
  176. Surgical treatment for female stress urinary incontinence: what is the gold-standard procedure?
  177. Botulinum Neurotoxin Type A: The Poison that Can Treat the Sick
  178. Editorial Comment on: Treatment with Propiverine in Children Suffering from Nonneurogenic Overactive Bladder and Urinary Incontinence: Results of a Randomized Placebo-Controlled Phase 3 Clinical Trial
  179. Precursor Isoform of Prostate-Specific Antigen and Human Kallikrein 2: Two New Promising Biomarkers for the Unsolved Challenge of Early Prostate Cancer Detection
  180. Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: Multi‐institutional dataset from three European centers
  181. Multioperated Recurrent Incontinence/Prolapse
  182. Multioperated Recurrent Incontinence/Prolapse
  183. Editorial Comment on: Cytological Punctures in the Diagnosis of Renal Tumours: A Study on Accuracy and Reproducibility
  184. Impact of Surgical and Medical Castration on Serum Testosterone Level in Prostate Cancer Patients
  185. The ‘Stage, Size, Grade and Necrosis’ score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer‐specific survival in patients with clear cell renal cell carcinoma
  186. Varicocele is associated with an increase of connective tissue of the pampiniform plexus vein wall
  187. Editorial Comment on: Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy
  188. Editorial Comment on: The Impact of Temporal Presentation on Clinical and Pathological Outcomes for Patients With Sporadic Bilateral Renal Masses
  189. Editorial Comment on: Is Botulinum Neurotoxin Type A (BoNT-A) a Novel Therapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement? A Review of the Literature
  190. A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder
  191. Editorial Comment on: Anatomical Mapping of Lymphatic Drainage in Penile Carcinoma with SPECT-CT: Implications for the Extent of Inguinal Lymph Node Dissection
  192. Scintigraphic renal function after unilateral pyeloplasty in children: a systematic review
  193. Re: Kyu-Sing Lee, Myung-Soo Choo, Chin Kyung Doo, et al. The Long Term (5-Years) Objective TVT Success Rate Does not Depend on Predictive Factors at Multivariate Analysis. A Multicentre Retrospective Study. Eur Urol 2008; 53:176–83
  194. Editorial Comment on: Update on the Medical Treatment of Metastatic Renal Cell Carcinoma
  195. The New Medical Treatment of Metastatic Renal Cell Carcinoma: A Good Debut, A Lot of Open Questions
  196. Editorial Comment on: Does Physiotherapist-Guided Pelvic Floor Muscle Training Reduce Urinary Incontinence After Radical Prostatectomy? A Randomised Clinical Trial
  197. Editorial Comment on: Treatment of Bladder Pain Syndrome/Interstitial Cystitis 2008: Can We Make Evidence-Based Decisions?
  198. Editorial Comment on: Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia
  199. Editorial Comment on: Recurrence Patterns of Squamous Cell Carcinoma of the Penis: Recommendations for Follow-Up Based on a Two-Centre Analysis of 700 Patients
  200. Urinary Incontinence: Ensure That the Patient's Voice is Heard
  201. Editorial Comment on: First Analysis of the Long-Term Results with Transrectal HIFU in Patients with Localized Prostate Cancer
  202. Rebuttal from Author re: Massimo Lazzeri and Giacomo Novara. Urinary Incontinence: Ensure That the Patient's Voice is Heard. Eur Urol 2008;53:1125–27
  203. Editorial Comment on: Symptom Bother and Health Care–Seeking Behavior among Individuals with Overactive Bladder
  204. Cancer-Related Outcome and Learning Curve in Retropubic Radical Prostatectomy: “If You Need an Operation, the Most Important Step is to Choose the Right Surgeon”
  205. Surgical Outcomes After Modified Antegrade Scrotal Sclerotherapy: A Prospective Analysis of 700 Consecutive Patients With Idiopathic Varicocele
  206. Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Results from a prospective, unrandomized, comparative study
  207. Risk stratification and prognostication of renal cell carcinoma
  208. Editorial Comment on: Botulinum Toxin A Detrusor Injections in Patients with Neurogenic Detrusor Overactivity Significantly Decrease the Incidence of Symptomatic Urinary Tract Infections
  209. Editorial Comment on: TVT-O for the Treatment of Female Stress Urinary Incontinence: Results of a Prospective Study after a 3-Year Minimum Follow-up
  210. Complication Rates of Tension-Free Midurethral Slings in the Treatment of Female Stress Urinary Incontinence: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Tension-Free Midurethral Tapes to Other Surgical Procedures an...
  211. How Accurately Do Solsona and European Association of Urology Risk Groups Predict for Risk of Lymph Node Metastases in Patients with Squamous Cell Carcinoma of the Penis?
  212. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract
  213. Learning Curve and Preliminary Experience with da Vinci-Assisted Laparoscopic Radical Prostatectomy
  214. Stem Cell Therapy in the Treatment of Stress Urinary Incontinence: A Significant Step in the Right Direction?
  215. Mathematical Models for Prognostic Prediction in Patients with Renal Cell Carcinoma
  216. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma
  217. Prostate Biopsy: The Transperineal Approach
  218. Collecting Duct Renal Cell Carcinoma: A Matched Analysis of 41 Cases
  219. Independent predictors of cancer‐specific survival in transitional cell carcinoma of the upper urinary tract
  220. Tension-Free Midurethral Slings in the Treatment of Female Stress Urinary Incontinence: A Systematic Review and Meta-analysis of Randomized Controlled Trials of Effectiveness
  221. A New Staging System for Locally Advanced (pT3–4) Renal Cell Carcinoma: A Multicenter European Study Including 2,000 Patients
  222. Prolapse surgery: an update
  223. Myoblasts and fibroblasts in stress urinary incontinence
  224. Reply to Benedict T. Blake-James and Mark Emberton’s Letter to the Editor re: Giacomo Novara, Antonio Galfano, Vincenzo Ficarra and Walter Artibani. Anticholinergic Drugs in Patients with Bladder Outlet Obstruction and Lower Urinary Tract Symptoms: A S...
  225. Re: Giacomo Novara, Antonio Galfano, Vincenzo Ficarra and Walter Artibani. Anticholinergic Drugs in Patients with Bladder Outlet Obstruction and Lower Urinary Tract Symptoms: A Systematic Review. Eur Urol 2006;50:675–83
  226. Prognostic factors in squamous cell carcinoma of the penis
  227. Proposal for Reclassification of the TNM Staging System in Patients with Locally Advanced (pT3–4) Renal Cell Carcinoma According to the Cancer-Related Outcome
  228. Grading Systems in Renal Cell Carcinoma
  229. Evidence from Robot-Assisted Laparoscopic Radical Prostatectomy: A Systematic Review
  230. Short‐term outcome after high‐intensity focused ultrasound in the treatment of patients with high‐risk prostate cancer
  231. Anticholinergic Drugs in Patients with Bladder Outlet Obstruction and Lower Urinary Tract Symptoms: A Systematic Review
  232. Critical Assessment of Pelvic Floor Surgical Reconstruction Outcome
  233. Prognostic Role of the Histologic Subtypes of Renal Cell Carcinoma after Slide Revision
  234. Needle Core Length is a Quality Indicator of Systematic Transperineal Prostate Biopsy
  235. Imaging for urinary incontinence: a contemporary perspective
  236. Nomogram Predictive of Cancer Specific Survival in Patients Undergoing Partial or Total Amputation for Squamous Cell Carcinoma of the Penis
  237. Nomogram Predictive of Pathological Inguinal Lymph Node Involvement in Patients With Squamous Cell Carcinoma of the Penis
  238. A 3-month preclinical trial to assess the performance of a new TVT-like mesh (TVTx) in a sheep model
  239. Critical Review of Guidelines for BPH Diagnosis and Treatment Strategy
  240. Inflammation, Apoptosis, and BPH: What is the Evidence?
  241. External Validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) Score to Predict Cancer Specific Survival Using a European Series of Conventional Renal Cell Carcinoma
  242. Twelve‐month self‐reported quality of life after retropubic radical prostatectomy: a prospective study with Rand 36‐Item Health Survey (Short Form‐36)
  243. An Unusual Inguino-Scrotal Presentation of Disseminated Peritoneal Adenomucinosis
  244. The International Continence Society terminology for the lower urinary tract: the importance of standardization
  245. The Potential Impact of Prostate Volume in the Planning of Optimal Number of Cores in the Systematic Transperineal Prostate Biopsy
  246. Proposal for revision of the TNM classification system for renal cell carcinoma
  247. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma
  248. Surgery for pelvic organ prolapse: current status and future perspectives
  249. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma
  250. Prognostic Factors in a Recent Series of Patients Treated with Radical Cystectomy for Bladder Cancer
  251. Original and reviewed nuclear grading according to the Fuhrman system
  252. Neoplasm Staging and Organ-Confined Renal Cell Carcinoma: A Systematic Review
  253. Modified antegrade scrotal sclerotherapy in adolescent patients with varicocele
  254. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
  255. Tumor-size breakpoint for prognostic stratification of localized renal cell carcinoma
  256. Pain assessment after original transperineal prostate biopsy using a coaxial needle
  257. Is Laparoscopic Radical Prostatectomy Better Than Traditional Retropubic Radical Prostatectomy?
  258. Campanus of Novara